SEATTLE, August 05, 2021, (MEDGADGET) — Global Digital PCR and Real-time PCR (qPCR) Market Analysis
Polymer chain reaction (PCR) uses polymerase enzymes, primers, and numerous heat cycles to make infinite copies of DNA from a single strand. Since PCR tests are performed in automated thermal cyclers, they are less susceptible to cross-contamination. dPCR and qPCR are typical diagnostic procedures utilized in research, pharmaceutical, and biotech institutes, and they are used in a wide range of applications.
Real-time PCR enables for precise and early illness diagnosis, as well as rapid and targeted patient therapy. In addition, because PCR techniques are more precise and have become an essential element of laboratory diagnosis, they have supplanted traditional infectious disease detection systems such as immunoassays, boosting market expansion.
*The Sample consists of Table of Content, Research framework of the actual report & research methodology adopted for it.
Download Free PDF Sample: https://www.coherentmarketinsights.com/insight/request-pdf/2368
The global digital PCR and real-time PCR (qPCR) market is projected to expand due to the vast development of qPCR in medical diagnostics to detect RNA viruses such as HIV and hepatitis C. Globally, about 36.7 million individuals were infected with the human immunodeficiency virus (HIV) in 2017, and around 400 million people were infected with viral hepatitis, as per the International Journal of Nanomedicine. Early diagnosis is a key component in managing AIDS patients, according to the report as there is no proven therapy for HIV infection, which is a major source of morbidity and mortality worldwide.
Furthermore, the introduction of technologically sophisticated goods is projected to boost growth of the global digital PCR and real-time PCR (qPCR) market over the forecast period. GNA Biosolutions GmbH introduced the Pharos V8 platform, a laser-based ultrafast PCR technology, in November 2013. The platform employs nanomaterial to speed up the PCR process by a factor of 10, making it ideal for usage in time-critical situations.
However, the global digital PCR and real-time PCR (qPCR) market is set to be hampered by high device costs and the use of alternative assays for illness detection and analysis.
“Limited Time Offer”
Buy This Research Study Report With Flat US $2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/2368
Due to the rising number of cancer patients, which favors the need for PCR diagnostic tools and assays, North America is anticipated to retain a prominent position in the global digital PCR and real-time PCR (qPCR) market. As per the National Cancer Institute, an estimated 1,735,350 million new cancer cases would be diagnosed in the U.S. in 2016, with 609,640 cancer deaths expected in 2018. By 2024, the majority of cancer patients is anticipated to increase to 19 million.
Major companies contributing in the global digital PCR and real-time PCR (qPCR) market are Qiagen N.V., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Bio-Rad Laboratories, Inc., Becton, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Dickinson and Company, Merck KGaA, Danaher Corporation, and Takara Bio, Inc.
To get detailed table of content (ToC), please click – https://www.coherentmarketinsights.com/ongoing-insight/toc/2368
Applied Biosystems QuantStudio 6 and 7 Pro Real-Time PCR Systems were released in April 2019 by Thermo Fisher Scientific Inc., and contain additional features such as facial recognition, voice control, and radiofrequency identity.
QIAGEN N.V. stated in January 2019 that it was developing a variety of next-generation systems for digital polymerase chain reaction (digital PCR or dPCR), one of the fastest-growing molecular diagnostic applications, with a 2020 launch planned.
Bio-Rad Laboratories, Inc. released the iQ-Check Enterobacteriaceae real-time PCR detection kit in 2017, which can test 94 samples.
To extend its molecular diagnostic offering, Agilent Technologies Inc. released AriaDx Real-Time PCR System for Clinical Diagnostics in Europe in 2017.
Danaher Corporation bought Cepheid Inc. in 2016 to extend its qPCR product line.
Table of Content
Global Digital PCR and Real-time PCR Market Research Report
Section 1: Global Digital PCR and Real-time PCR Industry Overview
Section 2: Global Economic Impact on Digital PCR and Real-time PCR Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Digital PCR and Real-time PCR Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Digital PCR and Real-time PCR Market Forecast
Other Related Reports:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027